Pharmaceutical Manufacturing – Mesalamine 1200mg Tablets

Nac Pharmaceuticals is seeking a qualified contractor to manufacture Mesalamine 1200mg enteric-coated delayed-release tablets in strict compliance with FDA current Good Manufacturing Practices. The product must meet all contract-specific National Drug Code requirements and labeling specifications as outlined in the agreement. This subcontract opportunity is open to manufacturers capable of producing high-quality oral solid dosage forms under cGMP standards with full traceability and documentation. The solicitation was posted on April 23, 2026, with proposals due by June 9, 2026, at 7:30 PM Eastern Time. The work is associated with the NAICS code 325412 for pharmaceutical preparation manufacturing and is being procured on behalf of the Department of Veterans Affairs. While no set-aside designation or point of contact details are provided, the place of performance and agency address remain unspecified, indicating flexibility in production location subject to regulatory and quality assurance requirements.